Pfizer drops £69bn AstraZeneca takeover bid

clock

US drugs giant Pfizer has withdrawn its £55 a share, £69bn takeover bid for UK pharmaceutical firm AstraZeneca.

It said: "Following the AstraZeneca board's rejection of the proposal, Pfizer announces that it does not intend to make an offer," the BBC reports. AstraZeneca's chairman, Leif Johansson, said it would "continue building on the momentum we have already demonstrated as an independent company." AstraZeneca had fiercely resisted the bid, backed by some politicians. It rejected a final offer from Pfizer earlier this month, saying the proposal undervalued the company and its "attractive prospects". Nevertheless, in recent weeks some AstraZeneca shareholders had said they wanted the f...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Equities

Will a tech shake-up stop the rise of passives?

Will a tech shake-up stop the rise of passives?

'That kind of built-in safety net is hard to beat'

Laura Suter
clock 18 February 2025 • 2 min read
Making sense of the great UK equity sell-off

Making sense of the great UK equity sell-off

Ongoing M&A activity proves alluring for some buyers

Darius McDermott
clock 31 January 2025 • 5 min read
Why investing in Asia is the real deal

Why investing in Asia is the real deal

Accumulating as much insight as possible

Gabriel Sacks
clock 31 January 2025 • 5 min read